Inspection prep notes · Data and records
Data integrity
Also called: ALCOA
FDA looks less at whether a data integrity policy exists than at who created a record, when, and whether it could be changed or deleted, checking this directly on instruments and documents. The findings below are quoted from warning letters and Form 483s.
What inspectors cited
1Electronic raw data could be deleted or modified
Specifically, electronic raw data used for release testing of batches (e.g., (b)(4) ) currently in the U.S. market was deleted and not accessible.
FDA Warning Letter · Outin Futures Corp. · 2024-10-15 · View document
For example, on November 21, 2025, your R&D personnel demonstrated that the raw data generated from confirmation testing stored in computer folder [redacted] can be potentially modified and deleted.
FDA 483 · Baxter Healthcare Corporation · 2026-10-30 · View document
2Laboratory instruments had no audit trail
For example, your ultraviolet-visible (UV-vis) and infrared (IR) spectroscopy equipment was found to lack audit-trail functionality, and your analysts were able to alter and delete data, files, and folders.
FDA Warning Letter · Guangxi Yulin Pharmaceutical Group Co. Ltd. · 2025-10-21 · View document
UV which uses software UV Probe 2.70 (equipment # QC/INST/13) does not have audit trail capabilities.
FDA 483 · Zen Chemicals Pvt. Ltd · 2026-10-19 · View document
3Records were pre-signed or backdated instead of made at the time of the work
Five blank preventative maintenance documents were discovered during the inspection that had been pre-signed and dated to January 9, 2025, in the “Performed by” section.
FDA Warning Letter · Tentamus India Private Limited · 2026-03-10 · View document
Your firm’s Deputy General Manager explained a procedural handling of documentation whereby the sterilization start time is not contemporaneously documented. Subsequently, a backdated sterilization start time was entered.
FDA 483 · Serum Institute of India Private Ltd. · 2026-10-26 · View document
4Original records and test evidence were discarded
However, your team leader had instructed staff to discard the bioburden plates with significant growth and had manipulated camera timestamps to create backdated documentation.
FDA Warning Letter · Huons Co., Ltd. · 2026-06-23 · View document
During our walkthrough of the QC laboratory on January 19, 2026, a discarded printout was found in a trash bin.
FDA 483 · Shimoga Chemicals · 2026-10-23 · View document
5User accounts and passwords were shared
The inspection documented that “System Administrator” was the only user type attributable in the (b)(4) Software and laboratory personnel shared a common password for the Windows and (b)(4) software systems.
FDA Warning Letter · Persōn & Covey, Inc. · 2025-09-30 · View document
Additionally, the pH meter does not have unique usernames and logins for individual operators. Instead, a shared username, "Analyst," is used by personnel.
FDA 483 · Fagron Analytical Services, LLC · 2026-10-26
Questions to check against your procedures
- Can an analyst with ordinary access delete or modify electronic raw data, files or folders? Has this been checked by demonstration?
- Can all electronic raw data used for release testing be retrieved today?
- Do standalone instruments such as UV, IR and pH meters also have an audit trail?
- Are there blank forms already signed and dated, or records dated back after the work? Are entries such as start times made at the moment of the work?
- Are printouts found in laboratory trash bins? Are printouts and plates from duplicate or failing tests also kept as records?
- Does each instrument have a unique account for each operator? Is testing ever done under a shared username, a shared password or an administrator account?
Compiled by AI from public findings and checked by a person. Quotations are verbatim from the original documents; (b)(4) marks text redacted in the original. As of 2026-11-15.